Search Results

Molecular imaging of bacterial biofilms-a systematic review.

• Authors : van Hoogstraten SWG; Laboratory for Experimental Orthopaedics, Department of Orthopaedic Surgery, CAPHRI, Maastricht University Medical Centre, Maastricht, the Netherlands.; Kuik C

Subjects: Biofilms*/Biofilms*/Biofilms*/growth & development ; Molecular Imaging*/Molecular Imaging*/Molecular Imaging*/methods ; Bacteria*/Bacteria*/Bacteria*/metabolism

• Source: Critical reviews in microbiology [Crit Rev Microbiol] 2024 Nov; Vol. 50 (6), pp. 971-992. Date of Electronic Publication: 2023 Jul 15.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8914274 Publication Model: Print-Electronic Cited

Record details

Nano-based drug delivery systems in hepatocellular carcinoma.

• Authors : Abtahi MS; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Department of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/administration & dosage

• Source: Journal of drug targeting [J Drug Target] 2024 Nov; Vol. 32 (9), pp. 977-995. Date of Electronic Publication: 2024 Jun 18.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print-Electronic Cited

Record details

Insight into the role of integrins and integrins-targeting biomaterials in bone regeneration.

• Authors : Tollabi M; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.; Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.

Subjects: Bone Regeneration*/Bone Regeneration*/Bone Regeneration*/drug effects ; Integrins*/Integrins*/Integrins*/metabolism ; Biocompatible Materials*/Biocompatible Materials*/Biocompatible Materials*/pharmacology

• Source: Connective tissue research [Connect Tissue Res] 2024 Sep; Vol. 65 (5), pp. 343-363. Date of Electronic Publication: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0365263 Publication Model: Print-Electronic Cited

Record details

Droplet-based microfluidics: an efficient high-throughput portable system for cell encapsulation.

• Authors : Dortaj H; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.; Amani AM

Subjects: Cell Encapsulation*/Cell Encapsulation*/Cell Encapsulation*/methods ; Regenerative Medicine*/Regenerative Medicine*/Regenerative Medicine*/methods ; Tissue Engineering*

• Source: Journal of microencapsulation [J Microencapsul] 2024 Sep; Vol. 41 (6), pp. 479-501. Date of Electronic Publication: 2024 Jul 30.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8500513 Publication Model: Print-Electronic Cited

Record details

Effectiveness of tolvaptan on renal replacement therapy in patients with autosomal dominant polycystic kidney disease: a retrospective cohort study from the TriNetX global collaborative network.

• Authors : Wu MJ; Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

Subjects: Tolvaptan*/Tolvaptan*/Tolvaptan*/therapeutic use ; Polycystic Kidney, Autosomal Dominant*/Polycystic Kidney, Autosomal Dominant*/Polycystic Kidney, Autosomal Dominant*/complications ; Polycystic Kidney, Autosomal Dominant*/Polycystic Kidney, Autosomal Dominant*/Polycystic Kidney, Autosomal Dominant*/drug therapy

• Source: Renal failure [Ren Fail] 2024 Dec; Vol. 46 (2), pp. 2412721. Date of Electronic Publication: 2024 Oct 18.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited

Record details

Codon optimized influenza H1 HA sequence but not CTLA-4 targeting of HA antigen to enhance the efficacy of DNA vaccines in an animal model.

• Authors : Anurogo D; International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC.; Faculty of Medicine and Health Sciences, Universitas Muhammadiyah Makassar, Makassar City, Indonesia.

Subjects: Vaccines, DNA*/Vaccines, DNA*/Vaccines, DNA*/immunology ; Vaccines, DNA*/Vaccines, DNA*/Vaccines, DNA*/genetics ; CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/genetics

• Source: Journal of immunotoxicology [J Immunotoxicol] 2024 Dec; Vol. 21 (1), pp. 2400624. Date of Electronic Publication: 2024 Sep 25.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101201960 Publication Model: Print-Electronic Cited

Record details

Artificial intelligence in nanotechnology for treatment of diseases.

• Authors : Heydari S; Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.; Masoumi N

• Source: Journal of drug targeting [J Drug Target] 2024 Aug 27, pp. 1-20. Date of Electronic Publication: 2024 Aug 27.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print-Electronic Cited

Record details

Adipose Tissue-Derived Mesenchymal Stromal Cells Modulate Inflammatory Response and Improve Allograft Islet Transplant in Mice Model of Type 1 Diabetes.

• Authors : Niknam B; Immunology Research Center (IRC), Iran University of Medical Sciences, Tehran, Iran.; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Subjects: Islets of Langerhans Transplantation* ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/blood

• Source: Endocrine research [Endocr Res] 2024 Aug-Nov; Vol. 49 (4), pp. 223-231. Date of Electronic Publication: 2024 Jul 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8408548 Publication Model: Print-Electronic Cited

Record details

The anti-cancer properties of miR-340 plasmid-chitosan complexes (miR-340 CC) on murine model of breast cancer.

• Authors : Kashefi S; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Mohammadi-Yeganeh S

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; Chitosan*/Chitosan*/Chitosan*/chemistry ; Plasmids*/Plasmids*/Plasmids*/genetics

• Source: Journal of drug targeting [J Drug Target] 2024 Aug; Vol. 32 (7), pp. 838-847. Date of Electronic Publication: 2024 Jun 04.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print-Electronic Cited

Record details

Biomechanical evaluation of porcine lens capsule with and without nucleus after capsulotomy - Finite element analysis.

• Authors : Wong YR; Biomechanics Laboratory, Singapore General Hospital, Singapore, Singapore.; Williams GP

• Source: Computer methods in biomechanics and biomedical engineering [Comput Methods Biomech Biomed Engin] 2024 Jun 17, pp. 1-8. Date of Electronic Publication: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9802899 Publication Model: Print-Electronic Cited

Record details